Research

17 results.

Hand pouring into measuring container in science lab
December 21, 2018 Three Van Andel Research Institute scientists named to list of most cited researchers in the world

GRAND RAPIDS, Mich. (Dec. 21, 2018) — Van Andel Research Institute-affiliated scientists Peter W. Laird, Ph.D., Stephen B. Baylin, M.D., and H. Eric Xu, Ph.D.,…

May 9, 2018 Fighting cancer is a team effort

Four years ago, we embarked on a collaborative endeavor to improve cancer treatment by establishing the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics…

May 15, 2017 Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences

VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…

May 15, 2017 VARI cancer researcher elected to National Academy of Sciences

GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

August 29, 2016 Vitamin C may boost effectiveness of acute myeloid leukemia treatment

EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any change to their…

VAI DEFAULT HEADER
November 5, 2015 TCGA findings provide molecular background for second most common kidney cancer

GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…

August 27, 2015 Researchers thwart cancer cells by triggering 'virus alert'

Note: This press release was written by John Hopkins Medicine. Dr. Stephen Baylin, who holds a joint appointment at Van Andel Research Institute (VARI) and at…